DE2127159C2 - IgG-Immunglobulinfraktion und ihre Herstellung - Google Patents

IgG-Immunglobulinfraktion und ihre Herstellung

Info

Publication number
DE2127159C2
DE2127159C2 DE19712127159 DE2127159A DE2127159C2 DE 2127159 C2 DE2127159 C2 DE 2127159C2 DE 19712127159 DE19712127159 DE 19712127159 DE 2127159 A DE2127159 A DE 2127159A DE 2127159 C2 DE2127159 C2 DE 2127159C2
Authority
DE
Germany
Prior art keywords
solution
igg
blood
plasma
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19712127159
Other languages
German (de)
English (en)
Other versions
DE2127159A1 (de
Inventor
Lars-Gunnar Stockholm Albinsson Falksveden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE
Original Assignee
STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE filed Critical STATENS BAKTERIOLOGISKA LABORATORIUM SOLNA SE
Publication of DE2127159A1 publication Critical patent/DE2127159A1/de
Application granted granted Critical
Publication of DE2127159C2 publication Critical patent/DE2127159C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19712127159 1970-06-02 1971-06-01 IgG-Immunglobulinfraktion und ihre Herstellung Expired DE2127159C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (es) 1970-06-02 1970-06-02

Publications (2)

Publication Number Publication Date
DE2127159A1 DE2127159A1 (de) 1971-12-09
DE2127159C2 true DE2127159C2 (de) 1981-12-24

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712127159 Expired DE2127159C2 (de) 1970-06-02 1971-06-01 IgG-Immunglobulinfraktion und ihre Herstellung

Country Status (8)

Country Link
AT (1) AT309678B (es)
CA (1) CA960964A (es)
CH (1) CH572745A5 (es)
DE (1) DE2127159C2 (es)
FR (1) FR2100716B1 (es)
GB (1) GB1344340A (es)
NL (1) NL177599C (es)
SE (1) SE348942B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2751717A1 (de) * 1976-12-03 1978-07-13 Myer Louis Dr Coval Neue verbesserte gammaglobuline fuer intravenoese injektion und verfahren zu ihrer herstellung

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (sv) * 1974-06-14 1976-11-15 P G S Lindroos Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
EP2376523A4 (en) * 2009-01-13 2012-11-28 Ge Healthcare Bio Sciences Ab Precipitation of biomolecules with negatively charged polymers
TWI445714B (zh) 2009-05-27 2014-07-21 Baxter Int 產製用於皮下使用之高濃度免疫球蛋白製備物之方法
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AR087953A1 (es) 2011-08-26 2014-04-30 Baxter Int Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
KR102673154B1 (ko) 2012-02-29 2024-06-05 다케다 야쿠힌 고교 가부시키가이샤 말초 신경의 IgG 자극된 재수초화
LT2961426T (lt) 2013-02-26 2019-12-27 Baxalta GmbH Centrinės nervų sistemos susirgimų gydymas, per nosį įvedant imunoglobuliną g
PT2994160T (pt) 2013-05-06 2019-08-07 Baxalta Inc Tratamento de sub-populações com doença de alzheimer com imunoglobulina g combinada
AU2023230335A1 (en) 2022-03-07 2024-08-29 Takeda Pharmaceutical Company Limited Affinity chromatographic production of clinical human igg products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (es) * 1962-01-03
BE713764A (es) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2751717A1 (de) * 1976-12-03 1978-07-13 Myer Louis Dr Coval Neue verbesserte gammaglobuline fuer intravenoese injektion und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
FR2100716A1 (es) 1972-03-24
CA960964A (en) 1975-01-14
NL177599C (nl) 1985-10-16
GB1344340A (en) 1974-01-23
DE2127159A1 (de) 1971-12-09
SE348942B (es) 1972-09-18
AT309678B (de) 1973-08-27
FR2100716B1 (es) 1975-06-06
CH572745A5 (es) 1976-02-27
NL177599B (nl) 1985-05-17
NL7107529A (es) 1971-12-06

Similar Documents

Publication Publication Date Title
DE2127159C2 (de) IgG-Immunglobulinfraktion und ihre Herstellung
DE2645466C2 (de) Verfahren zum Isolieren von Albumin aus Plasmaprodukten
EP0013901B1 (de) Verfahren zur Herstellung einer für die intravenöse Applikation geeigneten Immunglobulinlösung, die IgM in ankonzentrierter Form enthält
DE2720704C2 (de) Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung
DE60102144T2 (de) EINE METHODE ZUR HERSTELLUNG VON IgG
DE2801123C2 (de) Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
DE3218348A1 (de) Verfahren zur extraktion von proteinen, insbesondere von lactoferrin und immunglobulinen aus milch
EP0000134B1 (de) Glykoprotein, Verfahren zu seiner Herstellung, seine Verwendung zur Gewinnung von Antiserum sowie das Antiserum
EP0060491B1 (de) Protein (PP16), Verfahren zu seiner Anreicherung und Gewinnung sowie seine Verwendung
EP0033000B1 (de) Neues Protein PP15, ein Verfahren zu seiner Herstellung sowie seine Verwendung
DE2403994A1 (de) Herstellung von antisera
DE2742150C2 (es)
DE1617805C3 (de) Verfahren zur Gewinnung von Lysozym aus Eiweiß
DE2732998A1 (de) Verfahren zur herstellung von serumalbumin
CH632091A5 (en) Process for the preparation of an antiserum directed against placenta-specific glycoprotein
EP0035726B1 (de) Verfahren und diagnostisches Mittel zur direkten Bestimmung des Lipidgehaltes der beta-Lipoproteine des Blutes
DE69030414T2 (de) Reinigung von Albumin
DE3410694C2 (es)
DE1617332C3 (de) Verfahren zum Isolieren eines wasserlöslichen Protein-Metall-Chelats mit antiphlogistischer Wirkung
DE69632066T2 (de) Verfahren zur reinigung der urease aus helicobacter pylori
DE10065227A1 (de) Verfahren zur Isolierung und Reinigung von Eigelb-Antikörpern aus Vogeleiweiß und Verwendung von dadurch erhaltenen Eigelb-Antikörpern
DE2533183C3 (de) Verfahren zum Herstellen gereinigter Immunglobuline
DE3034529C2 (de) Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel
DE3022914A1 (de) Verfahren zurgewinnung eines anaphylatoxin und cocytotaxin enthaltenden leukotaxinpraeparates sowie von anaphylatoxin und cocytotaxin in molekular einheitlicher form
AT367297B (de) Verfahren zur herstellung eines serumeiweiss-pr[parates

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination